CD8A and glioblastoma: As the GBM microenvironment exhibits a pro-M2 phenotype, which is predominantly immunosuppressive, reprogramming TAM/M differentiation to a pro-inflammatory status may be a possible mechanism with which to re-activate suppressed CD8+ T cells.